Characterization of a new potent heparin. 3rd Communication: Determinations of anticoagulant activity of a new potent heparin preparation by thrombelastography in vitro using citrated dog and human blood.
The anticoagulant effect of a new potent heparin preparation was compared with a commercially available heparin by thrombelastography in vitro using citrated dog and human blood. The relative potency of the new heparin was found to be 1.45 to 1.77 with dog citrated blood and 1.77 to 2.41 with human citrated blood on the basis of different thrombelastographic parameters.
D000818:Animals; D000925:Anticoagulants; D002951:Citrates; D004285:Dogs; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D013916:Thrombelastography
D000925:Anticoagulants; D002951:Citrates; D006493:Heparin